Literature DB >> 34495179

Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification.

Bruno Guedes Baldi1,2, Suzana Erico Tanni3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34495179      PMCID: PMC8979668          DOI: 10.36416/1806-3756/e20210213

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  12 in total

1.  Pulmonary fibrosis secondary to COVID-19: a narrative review.

Authors:  Suzana Erico Tanni; Alexandre Todorovic Fabro; André de Albuquerque; Eloara Vieira Machado Ferreira; Carlos Gustavo Yuji Verrastro; Márcio Valente Yamada Sawamura; Sergio Marrone Ribeiro; Bruno Guedes Baldi
Journal:  Expert Rev Respir Med       Date:  2021-04-27       Impact factor: 3.772

2.  Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology.

Authors:  José Baddini-Martinez; Juliana Ferreira; Suzana Tanni; Luis Renato Alves; Benedito Francisco Cabral Junior; Carlos Roberto Ribeiro Carvalho; Talita Jacon Cezare; Claudia Henrique da Costa; Marcelo Basso Gazzana; Sérgio Jezler; Ronaldo Adib Kairalla; Leticia Kawano-Dourado; Mariana Silva Lima; Eliane Mancuzo; Maria Auxiliadora Carmo Moreira; Marcelo Palmeira Rodrigues; Silvia Carla Sousa Rodrigues; Adalberto Sperb Rubin; Rogério Lopes Rufino; Leila John Marques Steidle; Karin Storrer; Bruno Guedes Baldi
Journal:  J Bras Pneumol       Date:  2020-03-02       Impact factor: 2.624

3.  Chest x-ray or CT for COVID-19 pneumonia? Comparative study in a simulated triage setting.

Authors:  Nicola Sverzellati; Christopher J Ryerson; Gianluca Milanese; Elisabetta A Renzoni; Annalisa Volpi; Paolo Spagnolo; Francesco Bonella; Ivan Comelli; Paola Affanni; Licia Veronesi; Carmelinda Manna; Andrea Ciuni; Carlotta Sartorio; Giulia Tringali; Mario Silva; Emanuele Michieletti; Davide Colombi; Athol U Wells
Journal:  Eur Respir J       Date:  2021-02-11       Impact factor: 16.671

4.  Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan.

Authors:  Guido Giovannetti; Lucrezia De Michele; Michele De Ceglie; Paola Pierucci; Alessandra Mirabile; Marco Vita; Vincenzo Ostilio Palmieri; Giovanna Elisiana Carpagnano; Arnaldo Scardapane; Carlo D'Agostino
Journal:  Respir Med       Date:  2021-03-31       Impact factor: 3.415

5.  3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.

Authors:  Xiaojun Wu; Xiaofan Liu; Yilu Zhou; Hongying Yu; Ruiyun Li; Qingyuan Zhan; Fang Ni; Si Fang; Yang Lu; Xuhong Ding; Hailing Liu; Rob M Ewing; Mark G Jones; Yi Hu; Hanxiang Nie; Yihua Wang
Journal:  Lancet Respir Med       Date:  2021-05-05       Impact factor: 30.700

6.  Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.

Authors:  David T Arnold; Charmaine Donald; Max Lyon; Fergus W Hamilton; Anna J Morley; Marie Attwood; Alexandra Dipper; Shaney L Barratt
Journal:  PLoS One       Date:  2021-04-29       Impact factor: 3.240

7.  Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.

Authors:  Katherine Jane Myall; Bhashkar Mukherjee; Ana Margarida Castanheira; Jodie L Lam; Giulia Benedetti; Sze Mun Mak; Rebecca Preston; Muhunthan Thillai; Amy Dewar; Philip L Molyneaux; Alex G West
Journal:  Ann Am Thorac Soc       Date:  2021-05

8.  Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data.

Authors:  Elisa Baratella; Paola Crivelli; Cristina Marrocchio; Alessandro Marco Bozzato; Andrea De Vito; Giordano Madeddu; Laura Saderi; Marco Confalonieri; Luigi Tenaglia; Maria Assunta Cova
Journal:  J Bras Pneumol       Date:  2020-09-21       Impact factor: 2.624

9.  Respiratory follow-up of patients with COVID-19 pneumonia.

Authors:  Peter M George; Lisa G Spencer; Shaney L Barratt; Robin Condliffe; Sujal R Desai; Anand Devaraj; Ian Forrest; Michael A Gibbons; Nicholas Hart; R Gisli Jenkins; Danny F McAuley; Brijesh V Patel; Erica Thwaite
Journal:  Thorax       Date:  2020-08-24       Impact factor: 9.139

10.  Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil.

Authors:  Carlos Alberto de Castro Pereira; José Antonio Baddini-Martinez; Bruno Guedes Baldi; Sérgio Fernandes de Oliveira Jezler; Adalberto Sperb Rubin; Rogerio Lopes Rufino Alves; Gilmar Alves Zonzin; Manuel Quaresma; Matthias Trampisch; Marcelo Fouad Rabahi
Journal:  J Bras Pneumol       Date:  2019-09-16       Impact factor: 2.624

View more
  5 in total

1.  Pseudo-honeycombing in a patient with coronavirus disease 2019 pneumonia.

Authors:  Bruno Hochhegger; Gláucia Zanetti; Edson Marchiori
Journal:  Rev Soc Bras Med Trop       Date:  2022-02-25       Impact factor: 1.581

2.  Clinical, radiological, and transbronchial biopsy findings in patients with long COVID-19: a case series.

Authors:  Bruno Guedes Baldi; Alexandre Todorovic Fabro; Andreia Craveiro Franco; Marília Helena C Machado; Robson Aparecido Prudente; Estefânia Thomé Franco; Sergio Ribeiro Marrone; Simone Alves do Vale; Talita Jacon Cezare; Marcelo Padovani de Toledo Moraes; Eloara Vieira Machado Ferreira; André Luis Pereira Albuquerque; Marcio Valente Yamada Sawamura; Suzana Erico Tanni
Journal:  J Bras Pneumol       Date:  2022-04-29       Impact factor: 2.800

Review 3.  Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.

Authors:  Daniela Oatis; Erika Simon-Repolski; Cornel Balta; Alin Mihu; Gorizio Pieretti; Roberto Alfano; Luisa Peluso; Maria Consiglia Trotta; Michele D'Amico; Anca Hermenean
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

4.  Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We?

Authors:  Guilherme das Posses Bridi; Suzana Erico Tanni; Bruno Guedes Baldi
Journal:  Arch Bronconeumol       Date:  2022-08-13       Impact factor: 6.333

5.  Interstitial Lung Fibrosis Following COVID-19 Pneumonia.

Authors:  Mihai Lazar; Ecaterina Constanta Barbu; Cristina Emilia Chitu; Catalin Tiliscan; Laurentiu Stratan; Sorin Stefan Arama; Victoria Arama; Daniela Adriana Ion
Journal:  Diagnostics (Basel)       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.